Beynex Technologies OÜ is an Estonia-based digital cognitive health tools company, positioning its product as a “Digital Sensor for Cognitive Diseases.” Its core goal is to use AI-powered cognitive health solutions to help detect early signals of cognitive decline, while supporting intelligent monitoring and personalized care. The website indicates that it serves individuals, caregivers, and research institutions, and provides download links for Google Play and the App Store.
Beynex’s consumer-facing solution, Brain Health Coach, is designed for people who want to track their own cognitive health. It can regularly measure mental performance, analyze lifestyle habits, and provide personalized day-to-day recommendations. On the research side, Beynex emphasizes real-time data, longitudinal data, advanced analytics, and secure data tools, making it relevant for neuroscience, dementia prevention, healthy aging, and similar research scenarios. The website also mentions custom solutions based on research goals, allowing specific types of data to be collected.
The scraped content does not disclose subscription pricing, free quotas, trial policies, or enterprise/research quotation methods. It only shows prompts such as WhatsApp contact, “Let's Collaborate,” and “Request a Custom Solution.” As a result, the purchasing process appears to be more consultation-based or solution-driven. API, SDK, hospital system, or third-party platform integration capabilities are also not clearly described. For institutional deployment, data export, permission management, and system integration capabilities would need to be confirmed separately.
Beynex provides relatively detailed compliance claims. It states that its quality system complies with ISO 9001, its medical device processes comply with ISO 13485, its information security practices comply with ISO 27001, personal data follows GDPR, and health data processing complies with HIPAA. However, the website does not present details on the specific AI models used, training data sources, clinical validation results, accuracy, false-positive or false-negative rates, or the scope of regulatory approval. Therefore, based on the website information alone, it is better viewed as a cognitive health tracking, risk-alerting, and research data tool rather than a clinical diagnostic tool.
The main advantages are its vertical focus on cognitive diseases, coverage of three needs—personal self-assessment, caregiving, and research data—and its emphasis on long-term continuous data plus security and compliance. The drawbacks are limited transparency around commercial information, and the lack of clear evidence regarding Chinese-language support, pricing, APIs, and medical validity. It is suitable for individuals concerned about brain health, families caring for people with dementia, neuroscience research teams, and health management organizations to evaluate further.
Availability in mainland China, payment support, and app store accessibility are not explained on the website and should be considered unknown for now. If Google Play is unavailable, Android access may be affected. Alternative options include international cognitive assessment tools such as Cogstate, BrainCheck, and Linus Health, or cognitive screening services offered by local hospitals and health management platforms.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on beynex.com official site.
beynex.com is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach beynex.com directly.